
8.32 BATS BZX Real-Time Price As of 1:42pm ET | ![]() Today’s Change | 1.67 Today|||52-Week Range 8.46 | +32.70% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $660.5M |
CymaBay Therapeutics, Inc. 7575 Gateway Boulevard Newark California 94560 |
Sujal Shah | President, Chief Executive Officer & Director |
Daniel Menold | Vice President-Finance |
Charles A. McWherter | President-Research & Development |
Dennis D. Kim | Chief Medical Officer |
Paul T. Quinlan | Secretary & Chief Compliance Officer |